https://www.selleckchem.com/pr....oducts/cilengitide-e
n and glioma survival. The immunohistochemical staining results verified the progressive up-regulation of TNFRSF12A expression in normal brain, low-grade glioma, and high-grade glioma tissues. We concluded that TNFRSF12A was a viable prognostic biomarker and a potential immunotherapeutic target for glioma. We concluded that TNFRSF12A was a viable prognostic biomarker and a potential immunotherapeutic target for glioma. Extramammary Paget's disease (EMPD) sometimes spreads from the skin to mucosal areas, and cur
Like
Comment
Share
